These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8275943)

  • 1. Threonine for alanine substitution at position 109 of transthyretin differentially alters human transthyretin's affinity for iodothyronines.
    Rosen HN; Murrell JR; Liepnieks JJ; Benson MD; Cody V; Moses AC
    Endocrinology; 1994 Jan; 134(1):27-34. PubMed ID: 8275943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants.
    Rosen HN; Moses AC; Murrell JR; Liepnieks JJ; Benson MD
    J Clin Endocrinol Metab; 1993 Aug; 77(2):370-4. PubMed ID: 8345041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in structure of the N-terminal region of transthyretin produces change in affinity of transthyretin to T4 and T3.
    Prapunpoj P; Leelawatwatana L; Schreiber G; Richardson SJ
    FEBS J; 2006 Sep; 273(17):4013-23. PubMed ID: 16879610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
    Refetoff S; Marinov VS; Tunca H; Byrne MM; Sunthornthepvarakul T; Weiss RE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3335-40. PubMed ID: 8784093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroxine binding by human transthyretin variants: mutations at position 119, but not position 54, increase thyroxine binding affinity.
    Curtis AJ; Scrimshaw BJ; Topliss DJ; Stockigt JR; George PM; Barlow JW
    J Clin Endocrinol Metab; 1994 Feb; 78(2):459-62. PubMed ID: 7906282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia.
    Moses AC; Rosen HN; Moller DE; Tsuzaki S; Haddow JE; Lawlor J; Liepnieks JJ; Nichols WC; Benson MD
    J Clin Invest; 1990 Dec; 86(6):2025-33. PubMed ID: 1979335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin.
    Munro SL; Lim CF; Hall JG; Barlow JW; Craik DJ; Topliss DJ; Stockigt JR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1141-7. PubMed ID: 2498384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroxine-binding proteins--familial euthyroid hyperthyroxinemia due to point mutations of transthyretin].
    Hishinuma A; Mochizuki Y; Kasai K; Shimoda S
    Nihon Rinsho; 1994 Apr; 52(4):886-9. PubMed ID: 8196175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and functional analysis of normal and variant recombinant human transthyretin proteins.
    Murrell JR; Schoner RG; Liepnieks JJ; Rosen HN; Moses AC; Benson MD
    J Biol Chem; 1992 Aug; 267(23):16595-600. PubMed ID: 1644839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone affinity and fibril formation of piscine transthyretin: the role of the N-terminal.
    Morgado I; Melo EP; Lundberg E; Estrela NL; Sauer-Eriksson AE; Power DM
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):48-58. PubMed ID: 18620020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant transthyretin purification and competitive binding with organohalogen compounds in two gull species (Larus argentatus and Larus hyperboreus).
    Ucán-Marín F; Arukwe A; Mortensen A; Gabrielsen GW; Fox GA; Letcher RJ
    Toxicol Sci; 2009 Feb; 107(2):440-50. PubMed ID: 19033396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of 3,3',5,5'-tetraiodothyroacetic acid and 3,3',5'-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion.
    Everts ME; Visser TJ; Moerings EP; Tempelaars AM; van Toor H; Docter R; de Jong M; Krenning EP; Hennemann G
    Endocrinology; 1995 Oct; 136(10):4454-61. PubMed ID: 7664665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine binding to transthyretin (TTR) variants--two variants (TTR Pro 55 and TTR Met 111) with a particularly low binding affinity.
    Almeida MR; Saraiva MJ
    Eur J Endocrinol; 1996 Aug; 135(2):226-30. PubMed ID: 8810738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain.
    Chanoine JP; Alex S; Fang SL; Stone S; Leonard JL; Körhle J; Braverman LE
    Endocrinology; 1992 Feb; 130(2):933-8. PubMed ID: 1733735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nonesterified fatty acids and lysolecithins on thyroxine binding to thyroxine-binding globulin and transthyretin.
    Lim CF; Munro SL; Wynne KN; Topliss DJ; Stockigt JR
    Thyroid; 1995 Aug; 5(4):319-24. PubMed ID: 7488876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of little skate (Leucoraja erinacea) recombinant transthyretin: Zinc-dependent 3,3',5-triiodo-l-thyronine binding.
    Suzuki S; Kasai K; Yamauchi K
    Gen Comp Endocrinol; 2015; 217-218():43-53. PubMed ID: 25863347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroxine binding in a TTR Met 119 kindred.
    Alves IL; Divino CM; Schussler GC; Altland K; Almeida MR; Palha JA; Coelho T; Costa PP; Saraiva MJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):484-8. PubMed ID: 8102146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutation p.A64D in the Serpina7 gene as a cause of partial thyroxine-binding globulin deficiency associated with increases affinity in transthyretin by a known p.A109T mutation in the TTR gene.
    Sklate RT; Olcese MC; Maccallini GC; Sarmiento RG; Targovnik HM; Rivolta CM
    Horm Metab Res; 2014 Feb; 46(2):100-8. PubMed ID: 24356794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.
    Almeida MR; Damas AM; Lans MC; Brouwer A; Saraiva MJ
    Endocrine; 1997 Jun; 6(3):309-15. PubMed ID: 9368688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP).
    Furuya H; Saraiva MJ; Gawinowicz MA; Alves IL; Costa PP; Sasaki H; Goto I; Sakaki Y
    Biochemistry; 1991 Mar; 30(9):2415-21. PubMed ID: 1848097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.